GE HealthCare Technologies Inc. logo
GEHCGE HealthCare Technologies Inc.

Free Cash Flow Yield: 5.06%

Is the free cash flow yield high or low?

The free cash flow yield of 5.06% is 13% above its 4-year average of 4.49%, near the high end of its 4-year range (2.28%–5.89%).

As of Monday, June 29, 2026. 15.05% above its 12-month average of 4.40%.

Free Cash Flow Yield

GEHC Free Cash Flow Yield Chart

5.06%
+26.50% 1Y
GEHC Free Cash Flow Yield

GEHC Average Free Cash Flow Yield Chart

GEHC Free Cash Flow Yield

GEHC Current vs Average Free Cash Flow Yield Chart

GEHC Free Cash Flow Yield Metrics

FREE CASH FLOW YIELD

5.06%

FREE CASH FLOW YIELD AVG TTM

4.40%

FREE CASH FLOW YIELD AVG 3Y

4.53%

FREE CASH FLOW YIELD AVG 5Y

N/A

FREE CASH FLOW YIELD AVG 10Y

N/A

FREE CASH FLOW YIELD AVG 15Y

N/A

FREE CASH FLOW YIELD AVG 20Y

N/A

CURRENT VS TTM AVG

+15.05%

CURRENT VS 3Y AVG

+11.60%

CURRENT VS 5Y AVG

N/A

CURRENT VS 10Y AVG

N/A

CURRENT VS 15Y AVG

N/A

CURRENT VS 20Y AVG

N/A

GEHC Competitors' Free Cash Flow Yield

NAMEMARKET CAPFREE CASH FLOW YIELDTTM3Y5Y
GE HealthCare Technologies Inc. (GEHC)$29.91B5.06%4.40%4.53%N/A
ResMed Inc. (RMD)vs ›$29.05B5.93%4.80%3.89%2.78%
Zoetis Inc. (ZTS)vs ›$31.88B6.64%4.21%2.96%2.51%
Biogen Inc. (BIIB)vs ›$31.89B8.18%9.06%7.01%6.73%
IQVIA Holdings Inc. (IQV)vs ›$31.90B7.84%7.32%5.54%5.10%
Veeva Systems Inc. (VEEV)vs ›$27.84B5.78%3.74%3.15%2.79%
Centene Corp. (CNC)vs ›$32.44B19.49%15.80%12.34%12.36%
DexCom, Inc. (DXCM)vs ›$27.07B5.18%3.47%2.14%1.45%
Medline Inc. (MDLN)vs ›$32.87B4.76%4.80%4.80%4.80%
Moderna, Inc. (MRNA)vs ›$26.69BN/A8.49%9.09%9.09%

Yield Comparison

FCF Yield

5.06%

Earnings Yield

4.97%

Dividend Yield

0.21%

Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100

How FCF Yield is used:

  • Shows free cash flow after capital expenditures relative to market cap
  • Can be compared with earnings yield and dividend yield
  • Can be compared with the company's historical range
  • Can be compared with peers that report positive free cash flow

FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.

Free Cash Flow Yield Formula & Definition

FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Free Cash Flow Yield FAQ

What is the free cash flow yield for GE HealthCare Technologies Inc. (GEHC)?
The free cash flow yield for GEHC stock is 5.06%.
Is GE HealthCare Technologies Inc.'s free cash flow yield high or low?
The free cash flow yield of 5.06% is 13% above its 4-year average of 4.49%, near the high end of its 4-year range (2.28%–5.89%).
What is the TTM average free cash flow yield for GE HealthCare Technologies Inc. (GEHC)?
The TTM average free cash flow yield for GEHC stock is 4.40%.
What is the 3Y average free cash flow yield for GE HealthCare Technologies Inc. (GEHC)?
The 3Y average free cash flow yield for GEHC stock is 4.53%.

GEHC Free Cash Flow Yield History

DATEFREE CASH FLOW YIELD
2026-06-265.06%
2026-06-255.12%
2026-06-245.13%
2026-06-235.22%
2026-06-225.49%
2026-06-185.40%
2026-06-175.44%
2026-06-165.26%
2026-06-155.14%
2026-06-125.10%
2026-06-115.15%
2026-06-105.22%
2026-06-095.04%
2026-06-085.14%
2026-06-055.14%
2026-06-045.21%
2026-06-035.36%
2026-06-025.36%
2026-06-015.31%
2026-05-295.34%
2026-05-285.29%
2026-05-275.21%
2026-05-265.18%
2026-05-225.18%
2026-05-215.17%
2026-05-205.18%
2026-05-195.40%
2026-05-185.41%
2026-05-155.47%
2026-05-145.31%
2026-05-135.37%
2026-05-125.34%
2026-05-115.39%
2026-05-085.24%
2026-05-075.42%
2026-05-065.39%
2026-05-055.45%
2026-05-045.45%
2026-05-015.45%
2026-04-305.47%
2026-04-295.59%
2026-04-284.78%
2026-04-274.64%
2026-04-244.75%
2026-04-234.68%
2026-04-224.58%
2026-04-214.53%
2026-04-204.41%
2026-04-174.38%
2026-04-164.47%
2026-04-154.45%
2026-04-144.38%
2026-04-134.43%
2026-04-104.47%
2026-04-094.49%
2026-04-084.44%
2026-04-074.69%
2026-04-064.65%
2026-04-024.65%
2026-04-014.55%
2026-03-314.60%
2026-03-304.76%
2026-03-274.73%
2026-03-264.57%
2026-03-254.53%
2026-03-244.61%
2026-03-234.57%
2026-03-204.70%
2026-03-194.65%
2026-03-184.66%
2026-03-174.52%
2026-03-164.53%
2026-03-134.62%
2026-03-124.65%
2026-03-114.50%
2026-03-104.50%
2026-03-094.33%
2026-03-064.41%
2026-03-054.24%
2026-03-044.14%
2026-03-034.19%
2026-03-024.08%
2026-02-273.88%
2026-02-263.90%
2026-02-253.89%
2026-02-243.89%
2026-02-233.90%
2026-02-203.89%
2026-02-193.94%
2026-02-183.94%
2026-02-174.01%
2026-02-134.07%
2026-02-124.16%
2026-02-114.13%
2026-02-104.13%
2026-02-094.14%
2026-02-064.06%
2026-02-053.97%
2026-02-043.96%
2026-02-033.89%
2026-02-023.82%
2026-01-303.88%
2026-01-293.89%
2026-01-283.87%
2026-01-273.81%
2026-01-263.82%
2026-01-233.84%
2026-01-223.74%
2026-01-213.78%
2026-01-203.89%
2026-01-163.75%
2026-01-153.71%
2026-01-143.59%
2026-01-133.61%
2026-01-123.52%
2026-01-093.51%
2026-01-083.47%
2026-01-073.57%
2026-01-063.53%
2026-01-053.60%
2026-01-023.70%
2025-12-313.74%
2025-12-303.68%
2025-12-293.68%
2025-12-263.66%
2025-12-243.67%
2025-12-233.68%
2025-12-223.65%
2025-12-193.70%
2025-12-183.71%
2025-12-173.72%
2025-12-163.72%
2025-12-153.63%
2025-12-123.65%
2025-12-113.56%
2025-12-103.63%
2025-12-093.69%
2025-12-083.69%
2025-12-053.58%
2025-12-043.71%
2025-12-033.66%
2025-12-023.82%
2025-12-013.87%
2025-11-283.83%
2025-11-263.80%
2025-11-253.83%
2025-11-243.92%
2025-11-214.01%
2025-11-204.10%
2025-11-194.24%
2025-11-184.31%
2025-11-174.34%
2025-11-144.19%
2025-11-134.14%
2025-11-124.08%
2025-11-114.17%
2025-11-104.17%
2025-11-074.19%
2025-11-064.13%
2025-11-054.05%
2025-11-044.12%
2025-11-034.11%
2025-10-314.09%
2025-10-304.08%
2025-10-293.96%
2025-10-284.30%
2025-10-274.36%
2025-10-244.37%
2025-10-234.42%
2025-10-224.49%
2025-10-214.49%
2025-10-204.53%
2025-10-174.61%
2025-10-164.66%
2025-10-154.67%
2025-10-144.72%
2025-10-134.76%
2025-10-104.81%
2025-10-094.60%
2025-10-084.55%
2025-10-074.59%
2025-10-064.47%
2025-10-034.46%
2025-10-024.45%
2025-10-014.52%
2025-09-304.55%
2025-09-294.68%
2025-09-264.71%
2025-09-254.78%
2025-09-244.62%
2025-09-234.58%
2025-09-224.57%
2025-09-194.56%
2025-09-184.62%
2025-09-174.46%
2025-09-164.41%
2025-09-154.39%
2025-09-124.47%
2025-09-114.38%
2025-09-104.50%
2025-09-094.34%
2025-09-084.37%
2025-09-054.51%
2025-09-044.61%
2025-09-034.72%
2025-09-024.77%
2025-08-294.63%
2025-08-284.64%
2025-08-274.60%
2025-08-264.61%
2025-08-254.58%
2025-08-224.54%
2025-08-214.67%
2025-08-204.63%
2025-08-194.62%
2025-08-184.67%
2025-08-154.66%
2025-08-144.64%
2025-08-134.54%
2025-08-124.59%
2025-08-114.68%
2025-08-084.75%
2025-08-074.81%
2025-08-064.89%
2025-08-054.83%
2025-08-044.84%
2025-08-014.89%
2025-07-314.79%
2025-07-304.77%
2025-07-293.85%
2025-07-283.85%
2025-07-253.86%
2025-07-243.90%
2025-07-233.87%
2025-07-223.91%
2025-07-214.04%
2025-07-183.94%
2025-07-173.93%
2025-07-163.97%
2025-07-154.02%
2025-07-144.02%
2025-07-113.98%
2025-07-103.91%
2025-07-093.97%
2025-07-083.98%
2025-07-074.01%
2025-07-033.94%
2025-07-023.93%
2025-07-013.94%
2025-06-304.04%
2025-06-274.02%
2025-06-264.00%
2025-06-254.12%
2025-06-244.16%
2025-06-234.21%
2025-06-204.20%
2025-06-184.16%
2025-06-174.21%
2025-06-164.11%
2025-06-134.14%

Showing the most recent 260 of 884 data points. The chart above shows the full history.

About GE HealthCare Technologies Inc.

GE HealthCare Technologies Inc. is a global medical technology company that creates, manufactures, and markets a diverse range of medical devices, services, and integrated digital solutions. These offerings are designed to assist in the diagnosis, treatment, and ongoing monitoring of patients. The company boasts an extensive international presence, serving markets across the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, and Hong Kong, among other regions. Its operations are structured across four primary business divisions: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging division specializes in advanced diagnostic imaging technologies, including systems for molecular imaging, Computed Tomography (CT) scans, Magnetic Resonance (MR) imaging, image-guided therapy, and X-ray, alongside specialized women's health products. The Ultrasound segment delivers a comprehensive suite of ultrasound solutions utilized for the screening, diagnosis, treatment, and monitoring of various diseases. These applications span radiology, primary care, women's health, cardiovascular diagnostics, point-of-care, and portable handheld devices, in addition to products supporting surgical visualization and guidance. The Patient Care Solutions segment is dedicated to providing essential medical devices, consumable products, services, and digital platforms. Its portfolio encompasses patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, and maternal-infant care products. The Pharmaceutical Diagnostics segment supplies specialized diagnostic agents to the radiology and nuclear medicine industries. These include contrast media pharmaceuticals, administered to patients prior to scans like CT, angiography, X-ray, and MR, to enhance the visibility of internal tissues and structures. It also offers molecular imaging agents, or radiopharmaceuticals – molecular tracers labeled with radioisotopes – injected into patients for advanced diagnostic imaging applications such as Single-Photon Emission Computed Tomography (SPECT), Positron Emission Tomography (PET), and specific ultrasound procedures. Established in 2022, GE HealthCare Technologies Inc. maintains its corporate headquarters in Chicago, Illinois.

Chicago, IL
53,000 employees
Healthcare / Medical - Healthcare Information Services
Sector
Healthcare
Industry
Medical - Healthcare Information Services
CEO
Peter J. Arduini